FY2026 EPS Estimate for Core Scientific Decreased by Analyst

Core Scientific, Inc. (NASDAQ:CORZ) – Research analysts at B. Riley decreased their FY2026 earnings estimates for shares of Core Scientific in a research report issued on Wednesday, February 12th. B. Riley analyst N. Giles now anticipates that the company will earn $0.07 per share for the year, down from their previous forecast of $0.11. B. Riley has a “Buy” rating and a $17.00 price objective on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share.

Other equities research analysts have also recently issued research reports about the stock. Roth Mkm initiated coverage on shares of Core Scientific in a research report on Friday, November 15th. They issued a “buy” rating and a $25.50 target price for the company. Craig Hallum assumed coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They set a “buy” rating and a $24.00 target price on the stock. Macquarie lifted their price target on shares of Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. HC Wainwright raised their price objective on Core Scientific from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Finally, Jefferies Financial Group began coverage on Core Scientific in a report on Monday, October 28th. They set a “buy” rating and a $19.00 target price on the stock. Fifteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Core Scientific has a consensus rating of “Buy” and a consensus target price of $19.07.

Core Scientific Trading Up 0.6 %

Core Scientific stock opened at $12.16 on Thursday. The stock’s 50 day moving average is $14.36 and its 200-day moving average is $13.15. The company has a market capitalization of $3.40 billion and a price-to-earnings ratio of -2.24. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63.

Insider Buying and Selling at Core Scientific

In other news, Director Yadin Rozov sold 105,000 shares of the firm’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the completion of the transaction, the director now owns 345,239 shares of the company’s stock, valued at approximately $6,252,278.29. This trade represents a 23.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Adam Taylor Sullivan sold 88,380 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,258,531.20. Following the transaction, the chief executive officer now directly owns 4,128,505 shares of the company’s stock, valued at approximately $58,789,911.20. This represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 744,032 shares of company stock worth $11,863,966. 32.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Core Scientific

A number of institutional investors and hedge funds have recently made changes to their positions in CORZ. Vanguard Group Inc. grew its stake in Core Scientific by 54.3% in the fourth quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock valued at $272,270,000 after acquiring an additional 6,819,406 shares during the period. ORG Wealth Partners LLC lifted its stake in shares of Core Scientific by 0.3% in the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock valued at $126,262,000 after buying an additional 26,649 shares in the last quarter. Helix Partners Management LP bought a new stake in shares of Core Scientific during the fourth quarter worth about $86,498,000. Geode Capital Management LLC raised its holdings in shares of Core Scientific by 4.9% in the 4th quarter. Geode Capital Management LLC now owns 5,532,715 shares of the company’s stock worth $77,756,000 after acquiring an additional 256,142 shares during the last quarter. Finally, Parsifal Capital Management LP lifted its position in Core Scientific by 3.9% in the 3rd quarter. Parsifal Capital Management LP now owns 5,412,825 shares of the company’s stock valued at $64,196,000 after acquiring an additional 204,314 shares in the last quarter.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.